MedTrace Logo

Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment

NCT01123421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2012-10-15

No results posted yet for this study

Summary

Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS parameters will be able to discriminate between postmenopausal women with osteoporotic fractures when compared to matched controls without history of osteoporotic fracture.

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Aging (NIA)

    collaborator NIH

  • Mayo Clinic

    collaborator OTHER

  • Artann Laboratories

    lead INDUSTRY

Principal Investigators

  • Armen Sarvazyan, Ph.D., D.Sc. · Artann Laboratories, Inc.

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-04-30
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01123421 on ClinicalTrials.gov